Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 18/20 | 0.76 |
| ▸ | OXTR | P30559 | 1/20 | 0.59 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 2/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4356225 | 1.00 | AVPR1A (0.76) | AVPR1AOXTRAVPR2CNR1CNR2 | |
| SCHEMBL4363226 | 0.90 | AVPR1A (0.69) | AVPR1AOXTRAVPR2CNR1CNR2 | |
| SCHEMBL13603033 | 0.90 | AVPR1A (0.69) | AVPR1AOXTRAVPR2CNR1CNR2 | |
| SCHEMBL4363221 | 0.90 | AVPR1A (0.69) | AVPR1AOXTRAVPR2CNR1CNR2 | |
| SCHEMBL14160208 | 0.89 | AVPR1A (0.72) | AVPR1AOXTRAVPR2CNR1CNR2 | |
| Hydrochloric Acid SCHEMBL4358769 | 0.88 | AVPR1A (0.71) | AVPR1AOXTRAVPR2CNR1CNR2 | |
| Hydrochloric Acid SCHEMBL5137451 | 0.88 | AVPR1A (0.71) | AVPR1AOXTRAVPR2CNR1CNR2 | |
| SCHEMBL4356439 | 0.88 | AVPR1A (0.75) | AVPR1AOXTRAVPR2CNR1CNR2 | |
| SCHEMBL4360998 | 0.87 | AVPR1A (0.65) | AVPR1AOXTRAVPR2CNR1 | |
| SCHEMBL5136915 | 0.87 | AVPR1A (0.65) | AVPR1AOXTRAVPR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1904477-A1 | INDOL-3-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS | F. Hoffmann-Roche AG (CH) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007006688-A1 | INDOL-3-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-01-18 | — | — | WO | disclosed |